I
Intensity Therapeutics, Inc. (INTS)
6.03
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
6.03
0.00 (0.00%)
This stock has a consensus price target of $4.50 based on the ratings of 4 analysts. The high is $8.50 and the low is $1.50.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 1.5 | $ 4.5 | $ 8.5 |
| O’zgarish | -75.12% | -25.37% | 40.96% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2025-08-20 | 521.89% | Benchmark | $100 → $37.5 | Maintains | Speculative Buy |
| 2025-08-12 | 1143.78% | Brookline Capital | $75 | Upgrades | Hold → Buy |
| 2025-01-13 | 3424.05% | Alliance Global Partners | $212.5 | Initiates Coverage On | Buy |
| 2024-11-21 | 1972.97% | HC Wainwright & Co. | $125 → $125 | Reiterates | Buy |